Therapeutics
Developing Next Generation Therapeutics for Healthy Life
Pipeline
Immunology
-
Project(Partners)TargetIndicationRegionDiscoveryPreclinicalINDPH1PH2PH3BLA Filing
-
view more
Batoclimab HBM9161(Hanall)
FcRn
ITP
GO
MG
NMOSD
Second Wave of Indications
Greater
ChinaGreater
ChinaGreater
ChinaGreater
ChinaGreater
China -
view more
Tanfanercept HBM9036(Hanall)
TNFα
Dry Eye Disease
Greater
China -
HBM9378
undisclosed
undisclosed
undisclosed
-
HBM9022(AbbVie; Utrecht University; Erasmus MC)
SARS-COV-2
COVID-19
Global license to AbbVie
Oncology
-
Project(Partners)TargetIndicationRegionDiscoveryPreclinicalINDPH1PH2PH3BLA Filing
-
view more
HBM4003
CTLA-4
Advanced Solid Tumors
Advanced Melanoma&Other Solid Tumors
Advanced NSCLC&Other Solid Tumors
Global
Global
Global
-
HBM9302(Ichnos)
HER2xCD3
Breast Cancer and Gastric Cancer
Greater China
-
HBM1007
CD73
Solid Tumors
Global
-
HBM1029
Claudin 18.2
Solid Tumors
Ex-Greater China
-
HBM7020
BCMAxCD3
Multiple Myeloma
Ex-Greater China
-
HBM7015
PD-L1xTGF-β
Solid Tumors
Ex-Greater China
-
HBM7008
TAA1x4-1BB
Solid Tumors
Global
-
HBM1022
CCR8
Solid Tumors
Global
-
HBM
-
Partner
-
Directly Initiate PH 3 Study
-
Registrational Clinical Trial
-
Monotherapy
-
+ PD-(L )1
Target and other details not disclosed due to commercial sensitivity
